1Cardiac Arrhythmia Suppression Trial (CAST) Investigators.Preliminary report:effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction[J].N Engl J Med,1989,321:406-412.
2The Cardiac Arrhythmia Suppression Trial-Ⅱ Investigators.Effect of antiarrhythmic agent moricizine on survival after myocardial infarction:the Cardiac Arrhythmia Suppression Trial-Ⅱ[J].N Engl J Med,1992,327:223-227.
3WALDO A L,CAMM A J,DERUYTER H,et al.Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction.The SWORD Investigators.Survival With Oral d-Sotalol[J].Lancet,1996,348:7-12.
4ANDERSON J L,HALLSTROM A P,EPSTEIN A E,et al.Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry.The AVID Investigators[J].Circulation,1999,99:1692-1699.
5BOKHARI F,NEWMAN D,GREENE M,et al.Long-term comparison of the implantable cardioverter defibrillator versus amiodarone:eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)[J].Circulation,2004,110:112-116.
6Multicenter Unsustained Tachycardia Trial Investigators.Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial[J].Circulation,2002,106:233-238.
7HAISSAGUERRE M,SHAH D C,JAIS P,et al.Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation[J].Lancet,2002,359:677-678.
8QIN H,HUANG J,ROGEM J M,et al.Mechanisms for the maintenance of ventricular fibrillation:the nonuniform dispersion of refractoriness,restitution properties,or anatomic heterogeneities?[J].J Cardiovasc Electrophysiol,2005,16:888-897.
9HAISSAGUERRE M,SHODA M,JAIS P,et al.Mapping and ablation of idiopathic ventricular fibrillation[J].Circulation,2002,8:962-967.
2GuoCJ ZhangYC FangDP.C1inica1 and e1ectrophysio1ogica1 studies on the initiating rhythm of the spontaneous and induced ventricu1ar fibri11ation[J].中国医药导刊,2002,4:154-154.
3Haissaguerre M, Shoda M, Jais P, et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation,2002, 106:962-967.
6Friedman PL, Stewart JR, Wit AL. Spontaneous and induced cardiac arrhythmias in subendocardial Purkinje fibers surviving extensive myocardial infarction in dogs. Circ Res,1973, 33:612-626.
7Lazzara R, EISherif N, Scherlag BJ. Electrophysiological properties of canine Purkinje cells in one-day-old myocardial infarction. Circ Res, 1973, 33:722-734.
8Nakagawa H, Beckman KJ, McClelland JM, et al. Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation,1993, 88:2607-2617.
9Kim YH, Xie F, Yashima M, et al. Role of papillary muscle in the generation and maintenance of reentry during ventricular tachycardia and fibrillation in isolatecl swine right ventricle. Circulation, 1999, 100:1450-1459.
3International Liaison Committee on Resuscitation.2005 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations[J].Resuscitation,2005,67(2/3):271-291.
4Niemann JT,Stratton SJ,Cruz B,et al.Outcome of out-of-hospital post counter shock asystole and pulseless electrical activity[J].Crit Care Med,2001,29(12):2366-2370.
5Brown CG,Dzwonczyk R,Werman HA,et al.Estimating the duration of ventricular fibrillation[J].Ann Emerg Med,1989,18(11):1181-1185.
6Eftestol T,Wik L,Sunde K,et al.Effects of cardiopulmonary resuscitation on predictors of ventricular fibrillation defibrillation success during out-of-hospital cardiac arrest[J].Circulation,2004,110(1):10-15.
7Callaham M,Braun O,Valentine W,et al.Prehospital cardiac arrest treated urban first responders:profile of patient response and prediction of outcome by ventricular fibrillation waveform[J].Ann Emerg Med,1993,22(11):1664-1677.
10R. Lehmann,G. Groenefeld,Priv.-Doz. Dr. C. W. Israel. Stroke complicating congenital sick sinus syndrome[J] 2007,Herzschrittmachertherapie & Elektrophysiologie(2):105～111
